title: Precursors in cancer epidemiology: aligning definition and function.
abstract: A precursor of a disease is a definable pathologic state that progresses directly to disease without a known intermediate step and whose presence substantially increases the likelihood of disease. Precancers, or precursors of cancer, can help provide detail about the dynamic pathogenesis process before clinical disease. Thereby, ascertainment of properly defined precancers can increase precision of estimates and power in epidemiologic and clinical studies. Besides providing targets for direct treatment and improving tools for risk assessment in screening programs, precancers can help establish temporal ordering of cause and effect; can identify relatively homogeneous subsets of cancer that have passed through a given precancer state; and provide a basis for choosing high-risk individuals for detailed longitudinal study. Although the most appropriate definition of the precancer will vary with its function in particular research or clinical applications, the proportion of cancers that progress from the precancer and risk of cancer progressing from the precancer can be important measures of the value of a precancer in translational efforts.
authors.affiliation: Biostatistics Branch, Division of Cancer Epidemiology and Genetics, 6120 Executive Blvd., Room 5050, National Cancer Institute, Bethesda, MD 20892, USA. WacholdS@mail.nih.gov
authors.forename: Sholom
authors.initials: S
authors.lastname: Wacholder
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D018450:Disease Progression; D006801:Humans; D009369:Neoplasms / Q000453:epidemiology* / Q000209:etiology / Q000473:pathology; D011230:Precancerous Conditions / Q000453:epidemiology* / Q000209:etiology / Q000473:pathology; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
chemical_list: D014408:Biomarkers, Tumor
references.citation: Genet Epidemiol. 2011 Sep;35(6):499-505
references.pmid: 21618605
references.citation: J Natl Cancer Inst. 2008 Nov 5;100(21):1488-91
references.pmid: 18957674
references.citation: Am J Epidemiol. 1998 May 15;147(10):911-3
references.pmid: 9596468
references.citation: Rev Panam Salud Publica. 1997 May;1(5):362-75
references.pmid: 9180057
references.citation: J Natl Cancer Inst. 1994 Jul 20;86(14):1053-7
references.pmid: 7802771
references.citation: Cancer Detect Prev. 2006;30(5):387-94
references.pmid: 17079091
references.citation: AIDS Clin Rev. 1997-1998;:129-43
references.pmid: 9305447
references.citation: N Engl J Med. 2002 Nov 21;347(21):1645-51
references.pmid: 12444178
references.citation: Cancer Discov. 2011 Oct;1(5):408-19
references.pmid: 22586631
references.citation: Rev Panam Salud Publica. 2004 Feb;15(2):75-89
references.pmid: 15030652
references.citation: Int J Cancer. 2014 Feb 1;134(3):497-507
references.pmid: 23568556
references.citation: J Natl Cancer Inst. 1993 Jun 16;85(12):958-64
references.pmid: 8388478
references.citation: J Natl Cancer Inst. 2008 Apr 2;100(7):513-7
references.pmid: 18364507
references.citation: JAMA. 2013 Jan 2;309(1):71-82
references.pmid: 23280227
references.citation: Lancet Oncol. 2008 May;9(5):425-34
references.pmid: 18407790
references.citation: Stat Med. 1989 Apr;8(4):431-40
references.pmid: 2727467
references.citation: Lancet. 1992 Mar 7;339(8793):576-80
references.pmid: 1347094
references.citation: J Natl Cancer Inst. 1994 Nov 2;86(21):1648-9
references.pmid: 7932831
references.citation: Lancet. 2007 Sep 8;370(9590):890-907
references.pmid: 17826171
references.citation: Epidemiology. 2011 Jul;22(4):599-606
references.pmid: 21543985
references.citation: Am J Epidemiol. 1998 May 15;147(10):903-10
references.pmid: 9596467
references.citation: Int J Cancer. 2012 Nov 15;131(10):2349-59
references.pmid: 22323075
references.citation: Control Clin Trials. 1991 Aug;12(4):457-61
references.pmid: 1657524
references.citation: Am J Epidemiol. 1999 Sep 15;150(6):547-51
references.pmid: 10489992
references.citation: J Infect Dis. 2011 Jul 1;204(1):94-102
references.pmid: 21628663
references.citation: Am J Obstet Gynecol. 2000 Nov;183(5):1232-7
references.pmid: 11084571
references.citation: Sex Transm Dis. 2007 Jul;34(7):494-502
references.pmid: 17237737
references.citation: J Natl Cancer Inst Monogr. 2003;(31):125-30
references.pmid: 12807956
references.citation: Ann Intern Med. 1996 Oct 1;125(7):605-13
references.pmid: 8815760
references.citation: J Natl Cancer Inst. 2010 Mar 3;102(5):315-24
references.pmid: 20157096
references.citation: Obstet Gynecol. 2009 Jan;113(1):18-25
references.pmid: 19104355
references.citation: Cancer Discov. 2013 Feb;3(2):148-57
references.pmid: 23299199
references.citation: J Natl Cancer Inst. 1990 Nov 21;82(22):1746-52
references.pmid: 2231769
references.citation: Am J Epidemiol. 1999 Jan 1;149(1):1-4
references.pmid: 9883787
references.citation: CA Cancer J Clin. 2013 Jan;63(1):57-81
references.pmid: 23258613
references.citation: Epidemiology. 2005 Jan;16(1):1-3
references.pmid: 15613938